Education
About Us
Working with TipRanks
Follow Us
Trulieve Cannabis (TSE:TRUL)
:TRUL
TRUL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$4.30 - C$19.00
Previous CloseN/A
Volume82.04K
Average Volume (3M)69.85K
Market Cap
$945.83M
Enterprise ValueC$2.23B
Total Cash (Recent Filing)$328.45M
Total Debt (Recent Filing)$823.78M
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Aug 06, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding167,851,060
10 Day Avg. Volume73,979
30 Day Avg. Volume69,854
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.73
Price to Sales (P/S)0.00
P/FCF Ratio-8.78
Enterprise Value/Market Cap2.36
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit3.08
Enterprise Value/Ebitda1.86
Forecast
1Y Price Target
$21.78Price Target Upside342.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Trulieve Cannabis News
PremiumCompany Announcements
Trulieve Cannabis Holds Annual Shareholder Meeting
PremiumCompany Announcements
Trulieve Cannabis to Participate in June 2025 Benzinga Conference
PremiumCompany Announcements
Trulieve Launches ‘Roll-Up for Justice’ Campaign to Support Cannabis ReformPremiumCompany Announcements
Trulieve Expands Ohio Presence with New Lorain Dispensary
PremiumCompany Announcements
Trulieve Cannabis Reports Strong Q1 2025 Performance
PremiumCompany Announcements
Trulieve Cannabis Reports Strong Q1 Despite Challenges
PremiumCompany Announcements
Trulieve Cannabis Reports Q1 2025 Financial ResultsBulls Say, Bears Say
Bulls Say
Financial GuidanceGuidance for Q4 includes gross margins above prior forecast with low single digit sequential growth in revenues.
Financial PerformanceTrulieve reported strong gross margins that led to EBITDA above expectations.
Financial PositionSizable cash pile creates optionality: With $356 million of cash on hand, Trulieve has plenty of firepower to invest in growth catalysts across the board.
Investment ProspectsGiven Trulieve’s healthy financial position, access to capital, and best-in-class profitability metrics, the stock is attractive for investors looking for cannabis exposure to a high-quality operator.
Bears Say
Market VolatilityVolatility in the stock is likely due to the Amendment 3 vote occurring in Florida.
Options Prices
Currently, No data available
---
Ownership Overview
12.58% Insiders
―
Mutual Funds
― Other Institutional Investors
87.42% Public Companies and Individual Investors
TRUL FAQ
What was Trulieve Cannabis’s price range in the past 12 months?
Trulieve Cannabis lowest stock price was C$4.30 and its highest was C$19.00 in the past 12 months.
What is Trulieve Cannabis’s market cap?
Trulieve Cannabis’s market cap is $945.83M.
When is Trulieve Cannabis’s upcoming earnings report date?
Trulieve Cannabis’s upcoming earnings report date is Aug 06, 2025 which is in 49 days.
How were Trulieve Cannabis’s earnings last quarter?
Trulieve Cannabis released its earnings results on May 07, 2025. The company reported -C$0.237 earnings per share for the quarter, missing the consensus estimate of -C$0.102 by -C$0.135.
Is Trulieve Cannabis overvalued?
According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued.
Does Trulieve Cannabis pay dividends?
Trulieve Cannabis does not currently pay dividends.
What is Trulieve Cannabis’s EPS estimate?
Trulieve Cannabis’s EPS estimate is -0.09.
How many shares outstanding does Trulieve Cannabis have?
Trulieve Cannabis has 167,851,060 shares outstanding.
What happened to Trulieve Cannabis’s price movement after its last earnings report?
Trulieve Cannabis reported an EPS of -C$0.237 in its last earnings report, missing expectations of -C$0.102. Following the earnings report the stock price went down -1.142%.
Which hedge fund is a major shareholder of Trulieve Cannabis?
Currently, no hedge funds are holding shares in TSE:TRUL
Trulieve Cannabis Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.78 (342.66% Upside)
$21.78 (342.66% Upside)
Blogger Sentiment
Bullish
TSE:TRUL Sentiment 90%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $46.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.6%
Last 30 Days ▼ 6.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.98%
12-Months-Change
Fundamentals
Return on Equity
-12.39%
Trailing 12-Months
Asset Growth
2.42%
Trailing 12-Months
Company Description
Trulieve Cannabis
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
TRUL Company Deck
TRUL Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a strong operational performance with increased revenue and improved margins, alongside significant growth in loyalty program and wholesale segments. However, challenges such as a slight decline in retail revenue and increased SG&A expenses contributed to a net loss for the quarter.Read More>TRUL Stock 12 Month Forecast
Average Price Target
C$21.78
▲(342.66%Upside)
Technical Analysis
Cronos Group
―
Curaleaf Holdings
―
Green Thumb Industries
―
Cresco Labs
―
DRI Healthcare
―